534
Views
13
CrossRef citations to date
0
Altmetric
Technology Evaluation

Technology evaluation: Kollicoat IR

, , , &
Pages 693-703 | Published online: 19 Mar 2011

Bibliography

  • DeMerlis CC, Schoneker DR. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol 2003;41:319-26
  • Jordan MP, Taylor J. Film coatings and film coating composition based on polyvinyl alcohol. EP1208143; 2004
  • Hogan JE. Film-coating materials and their properties. In: Pharmaceutical Coating Technology. Taylor & Francis Ltd, London, UK; 1995
  • BASF Aktiengesellschaft, Technical Information, Kollicoat IR; 2001
  • Kolter K, Gotsche M, Schneider T. Physicochemical characterization of Kollicoat IR. BASF ExAct 2002;8:2-3
  • Pal K, Banthia AK, Majumdar DK. Preparation and characterization of polyvinyl alcohol-gelatin hydrogel membranes for biomedical applications. AAPS PharmSciTech 2007;8(1): article 21, E1-E5
  • Tubbs RK. Melting point and heat of fusion of poly(vinyl alcohol). Part A: general papers. J Polym Sci 1965;3:4181-9
  • Gunsa S, Kayaert P, Martens JA, Characterization of the copolymer poly(ethyleneglycol-g-vinylalcohol) as a potential carrier in the formulation of solid dispersions. Eur J Pharm Biopharm 2010;74:239-47
  • Khan M. Excipient Challenges in the 21st Century: an FDA Perspective, International Excipient Workshop: Excipient Quality Control, Testing, and International Harmonization USP Headquarters, Rockville, Maryland 20 – 21 July 2009
  • BASF's Kollicoat IR receives first drug registration. The Pharma Letter. Putney, London, UK, 2005. Available from: http://www.thepharmaletter.com/file/19784/basfs-kollicoat-ir-receives-first-drug-registration.html [Last accessed 15 December 2010]
  • Pharmaceutical excipient for instant-release tablet coatings approved in USA Sourcews™. BASF Group, Ludwigshafen, Germany, 2008. Available from: http://www.sourcews.com/pharmaceutical-excipient-instant/sendtoafriend.html [Last accessed 15 December 2010]
  • Hoessel P. A new multifunctional polymer. Cosmet Toiletries 1996;111:73-7
  • Kolter K. Kollicoat® IR Innovation in instant release film coatings. BASF ExAct 2002;8:4-5
  • Kolter K. Scale-up of an Instant-Release Film-Coating Process with Kollicoat® IR. BASF ExAct 2002;9:2-3
  • Kolter K. Binding properties of the new polymer. BASF ExAct 2003;10:8-9
  • Kolter K. New Instant Release Coating, Viscosity and pigment binding capacity of Kollicoat® IR. BASF ExAct 2004;12:6-7
  • Ziegler R, Kolter K. Protection of light-sensitive active ingredients. BASF ExAct 2005;146-8
  • Cech T, Kolter K. Comparison of the coating properties of instant release film coating materials using newly developed test method-the process-parameter-chart Pharmaceutical sciences world congress, Amsterdam, The Netherlands, 22 – 25 April 2007
  • Six K, Verreck G, Peeters J, Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast and slow dissolving polymers. J Pharm Sci 2004;93:124-31
  • Wang X, Michoel A, Van den Mooter G. Solid state characterization of ternary solid dispersions composed of PVPVA 64, Myrj 64 and itraconazole. Int J Pharm 2005;303:54-61
  • Vilhelmsen T, Eliasen H, Schæfer T. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int J Pharm 2005;303:132-42
  • Van Drooge DJ, Hinrichs WL, Visser MR, Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapor sorption techniques. Int J Pharm 2006;310:220-29
  • Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci 1969;58:538-49
  • Karavas E, Georgarakis E, Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm 2006;64:115-26
  • Drooge DJV, Braeckmans K, Hinrichs WLJ, Characterization of the mode of incorporation of lipophilic compounds in solid dispersions at the nanoscale using fluorescence resonance energy transfer (FRET). Macromol Rapid Commun 2006;27:1149-55
  • Pokharkar VB, Mandpe LP, Padamwar MN, Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol 2006;167:20-5
  • Hasegawa S, Hamaura T, Furuyama N, Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int J Pharm 2005;3025:103-12
  • Lloyd GR, Craig DQ, Smith A. A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions. Eur J Pharm Biopharm 1999;48:59-65
  • Yoshihashi Y, Iijima H, Yonemochi E, Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry. J Therm Anal Calorim 2006;85:689-92
  • Prabhu S, Ortega M, Ma C. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int J Pharm 2005;301:209-16
  • Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci 2006;28:67-76
  • Guyot M, Fawaz F, Bildet J, Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm 1995;123:53-63
  • Yao W, Sun J, Zhu C, Thermodynamic properties for the system of silybin and poly(ethylene glycol) 6000. Thermochim Acta 2005;437:17-20
  • Chiou WL, Riegelman S. Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J Pharm Sci 1970;59:937-42
  • Ceballos A, Cirri M, Maestrelli F, Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. IL Farmaco 2005;60:913-18
  • Huang J, Wigent RJ, Bentzley CM, Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery: effect of drug loading on release kinetics. Int J Pharm 2006;3196:44-54
  • Tanaka N, Imai K, Okimoto K, Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation. J Control Release 2006;112:51-6
  • Ohara T, Kitamura S, Kitagawa T, Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int J Pharm 2006;302:95-102
  • Won D-H, Kim MS, Lee S, Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm 2005;301:199-208
  • Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 2006;95:2692-705
  • Tanaka N, Imai K, Okimoto K, Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Control Release 2005;1085:386-95
  • Verreck G, Decorte A, Heymans K, Hot stage extrusion of p-amino salicylic acid with EC using CO2 as a temporary plasticizer. Int J Pharm 2006;327:45-50
  • Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281-302
  • Goldberg AH, Gibaldi M, Kanig JL, Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol-urea system. J Pharm Sci 1966;55:581-3
  • Karata A, Yuksel N, Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. IL Farmaco 2005;60:777-82
  • Damian F, Blaton N, Naesens L, Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci 2000;10:311-22
  • Janssens S, De Armas HN, Remonc JP, The use of a new hydrophilic polymer, Kollicoat IR®, in the formulation of solid dispersions of itraconazole. Eur J Pharm Sci 2007;30:288-94
  • Janssens S, Anne M, Rombaut P, Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions. Eur J Pharm Sci 2009;37:241-8
  • EL-Badry M, Alanazi1 FK, Mahrous GM, Effects of Kollicoat IR® and hydroxypropyl-beta- cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules. Pharm Deve and Techn Pharm Deve and Techn2010;15:500-10
  • El-Badry M. Improvement of the in vitro release of omeprazole from suppository bases using Kollicoat IR. J Drug Del Sci Tech 2010;20:391-5
  • Wade A, Weller PJ. Handbook of pharmaceutical excipients. American Pharmaceutical Association, Washington; 1994
  • Amighi K, Moes AJ. Influence of plasticizer concentration and storage conditions on the drug release rate from Eudragit RS 30D film-coated sustained-release theophylline pellets. Eur J Pharm Biopharm 1996;42:29-35
  • Wu C, Mc-Ginity JW. Influence of relative humidity on the mechanical and drug release properties of theophylline pellets coated with an acrylic polymer containing methylparaben as a non-traditional plasticizer. Eur J Pharm Biopharm 2000;50:277-84
  • Siepmann F, Hoffmann A, Leclercq B, How to adjust desired drug release patterns from ethylcellulose-coated dosage forms, J Control Release 2007;119:182-9
  • Siepmann F, Muschert S, Leclercq B, How to improve the storage stability of aqueous polymeric film coatings. J Control Release 2008;126:26-33
  • Muschert S, Siepmann F, Leclercq B, Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Eur J Pharm Biopharm 2009;72:130-37
  • Muschert S, Siepmann F, Cuppok Y, Improved long term stability of aqueous ethylcellulose film coatings: importance of the type of drug and starter core. Int J Pharm 2009;368:138-45
  • Strubing S, Metz H, Syrowatka F, Monitoring of dissolution induced changes in film coat composition by 1H NMR spectroscopy and SEM. J Control Release 2007;119:190-6
  • Ensslin S, Moll KP, Metz H, Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release. Eur J Pharm Biopharm 2009;72:111-18
  • Ensslin S, Moll KP, Paulus K, New insight into modified release pellets – Internal structure and drug release mechanism. J Control Release 2008;128:149-56
  • Strubing S, Metz H, Mader K. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery. Eur J Pharm Biopharm 2007;66:113-19
  • Ensslin S, Moll KP, Haefele-Racin T, Safety and robustness of coated pellets: self-healing film properties and storage stability. Pharm Res 2009;26:1534-43
  • Muschert S, Siepmann F, Leclercq B, Prediction of drug release from ethylcellulose coated pellets. J Control Release 2009;135:71-9
  • Strubing S, Abboud T, Contri RV, New insights on poly(vinyl acetate)-based coated floating tablets: Characterization of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Eur J Pharm Biopharm 2008;69:708-17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.